Finally, we have previously observed that breast cancer cells with high ALDH activity and CD44 expression (ALDHhiCD44+ phenotype) are significantly more resistant to chemotherapy and radiation therapy, and that this therapy resistance may occur, at least in part, via ALDH1-dependent mechanisms [9]. Here, LDHA is linked to breast cancer.